LEP and diabetes mellitus: These peptides have been found to safely mimick the activity of leptin in mouse models of genetic and non-genetic obesity, diabetes, and cognitive impairment, thus overcoming the central and peripheral leptin resistance responsible for leptin’s failure in the clinic.